Allergan (AGN) Targeted By Valeant and Pershing Capital

Shares of Allergan Inc. (AGN) were up +28.33 or +19.95 percent to $170.33 per share in pre-market trading this morning, after news late yesterday of a potential takeover bid from Valeant Pharmaceuticals International Inc. (VRX) and Bill Ackman’s Pershing Square Capital Management LP. Allergan stock closed at $142.00 per share, up +8.08 or +6.03 percent Read the full article... Read the rest of Allergan (AGN) Targeted By Valeant and Pershing Capital at InvestorGuide.com .